Sintilimab Combined With Fruquintinib/Regorafenib ± Radiotherapy for Third-line Treatment of Advanced Metastatic Colorectal Cancer

Conditions: Colorectal Cancer; Immunotherapy; Radiotherapy; Targeted Therapy Interventions: Drug: Sintilimab Sponsors: Shandong Cancer Hospital and Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials